drugset / Trial / NCT00855686

Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

NCT00855686

Phase 4 Completed 199 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this exploratory study is to determine whether memantine can provide benefits on clinical symptoms in patients with Parkinson's Disease Dementia or Dementia with Lewy Bodies.

Timeline

Start
2007-01
Primary completion
2008-12
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 20 mg Oral